Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
British Journal of Cancer|July 23, 2020
Correction: Integrated single-cell and bulk gene expression and ATAC-seq reveals heterogeneity and early changes in pathways associated with resistance to cetuximab in HNSCC-sensitive cell linesLuciane T Kagohara, Fernando Zamuner, Emily F Davis-Marcisak, et al.British Journal of Cancer|May 5, 2020
Integrated single-cell and bulk gene expression and ATAC-seq reveals heterogeneity and early changes in pathways associated with resistance to cetuximab in HNSCC-sensitive cell linesLuciane T Kagohara, Fernando Zamuner, Emily F Davis-Marcisak, et al.Genome Medicine|August 11, 2021
Transfer learning between preclinical models and human tumors identifies a conserved NK cell activation signature in anti-CTLA-4 responsive tumorsEmily F Davis-Marcisak, Allison A Fitzgerald, Michael D Kessler, et al.Cancer Cell|July 30, 2021
From bench to bedside: Single-cell analysis for cancer immunotherapyEmily F Davis-Marcisak, Atul Deshpande, Genevieve L Stein-O'Brien, et al.Cancer Research|July 25, 2019
Differential Variation Analysis Enables Detection of Tumor Heterogeneity Using Single-Cell RNA-Sequencing DataEmily F Davis-Marcisak, Thomas D Sherman, Pranay Orugunta, et al.Plos Genetics|October 21, 2020
Evaluation of both exonic and intronic variants for effects on RNA splicing allows for accurate assessment of the effectiveness of precision therapiesAnya T Joynt, Taylor A Evans, Matthew J Pellicore, et al.American Journal of Respiratory and Critical Care Medicine|March 20, 2019
Correlating Cystic Fibrosis Transmembrane Conductance Regulator Function with Clinical Features to Inform Precision Treatment of Cystic FibrosisAllison F McCague, Karen S Raraigh, Matthew J Pellicore, et al.Cancer Immunology Research|February 24, 2022
Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2+ Breast Tumor MicroenvironmentDimitrios N Sidiropoulos, Christine I Rafie, Julie K Jang, et al.Pageof 1